This training on FDA compliance will provide the attendees with an understanding of FDA expectations regarding end-of-phase 2A meeting guidance. Attendees will learn the best practices to comply with the intent of the guidance and to achieve a higher quality outcome from the meeting.
Driving Quality and Compliance in Drug Development Through the FDA End-of-Phase 2A Meeting
23 January 2014, Palo Alto, United States
Introduction
Venue
Online Event
Online Event, 2600 E. Bayshore Road, Palo Alto, 94303, United States
Organised by
ComplianceOnlinr
Contact information
Related events
Integrating chemistry, engineering and biology to create the next generation of vaccines
30 March 2026 10:00-18:00, Cambridge, United Kingdom
8th International Conference on Nanomaterials Science and Mechanical Engineering
7 July 2026 08:00 - 10 July 2026 18:00, Aveiro, Portugal
Harnessing Green Chemistry and AI for Sustainable Development
4 November 2025 09:00 - 7 November 2025 08:00, Otuoke via Yenagoa, Nigeria
JPAG Pharmaceutical Analysis Research Awards & Carers Symposium 2025
11 November 2025 09:00-18:00, London, United Kingdom
Search
Advertisement
Spotlight
Explore
Membership
